Register Now: IKRIS Breast Cancer Awareness Run 2022


  • Active Ingredient/Generic Name - Somatropin
  • Packaging - Prefilled Pens
  • Strength - 5mg/1.5 mL, 10mg/1.5mL, 15mg/1.5mL, and 30mg/3mL

What is Somatropin, and what it is used for?

Somatropin is a recombinant human growth hormone (HGH) used for the treatment of children with growth failure due to the growth hormone deficiency (GHD), short stature associated with Turner syndrome, short stature associated with Noonan syndrome and short stature born SGA with no catch-up growth by age 2-4 years.
Somatropin is also used for the treatment of adults with either adult onset or childhood onset GHD.


The recommended dose of Somatropin Injection should be administered subcutaneously.

  • Pediatric GHD: The recommended dose is 0.024 to 0.034 mg/kg/day, 6 to 7 times a week.
  • Noonan Syndrome: The recommended dose is up to 0.066 mg/kg/day.
  • Turner Syndrome: The recommended dose is up to 0.067 mg/kg/day.
  • SGA: The recommended dose is up to 0.067 mg/kg/day.
  • Adult GHD: The recommended dose is 0.004 mg/kg/day to be increased as tolerated to not more than 0.016 mg/kg/day after around 6 weeks, or a starting dose of around 0.2 mg/day (range, 0.15-0.30 mg/day) increased gradually every 30-60 days by increments of round 0.1 to 0.2 mg daily. Injection sites should always be rotated to avoid lipoatrophy.
Side effects

The most commonly reported side effects due to Somatropin hgh include: headaches, injection site reactions/rashes and lipoatrophy.

Warnings and Precautions
  • There have been reports of fatalities after starting somatropin therapy in pediatric patients with Prader-Willi syndrome who had one or more of the following risk factors: severe obesity, history of sleep apnea or upper airway obstruction, or unidentified respiratory infection.
  • Patients with Prader-Willi syndrome should be assessed for signs of upper airway obstruction and sleep apnea prior to initiation of treatment with somatropin recombinant growth hormone.
  • Patients with Prader-Willi syndrome treated with somatropin medication should also have effective weight control and be assessed for signs/symptoms of respiratory infection, which should be diagnosed as early as possible and treated aggressively.
  • Monitor patients with a history of GHD secondary to an intracranial neoplasm routinely while taking treatment with hormone somatropin for progression or recurrence of the tumor.
  • In case somatropin treatment is initiated, patients should be carefully evaluated for development of neoplasms. Assess patients carefully for increased growth, or potential malignant changes, of pre existing nevi.
    Patients with preexisting type-1/2 diabetes mellitus or impaired glucose tolerance should be assessed precisely while on somatropin therapy. The doses of antihyperglycemic drugs may require adjustment when somatropin treatment is instituted in these patients.
  • Funduscopic examination needs to be performed routinely prior to initiating somatropin hgh to exclude preexisting papilledema, and periodically during somatropin therapy. In case papilledema is observed by funduscopy during treatment, treatment needs to be stopped.
  • In patients with multiple hormone deficiencies, standard hormonal replacement therapy needs to be monitored precisely when this medication is administered.
  • Patients with Turner syndrome need to be assessed carefully for otitis media and other ear disorders since these patients have a greater risk of ear and hearing disorders. The somatropin use may be responsible for increasing the occurrence of otitis media in patients with Turner syndrome.
  • When somatropin medicine is administered subcutaneously at the same site over a long period of time, tissue atrophy may result. This may be avoided by rotating the site of injection.
How Supplied/Storage and handling:

The unused somatropin injection must be stored at 2°C to 8°C/36°F to 46°F (refrigerator). Do not freeze. Avoid direct light. After the initial injection, a Somatropin FlexPro prefilled pen may be either stored in the refrigerator (2°C to 8°C/36°F to 46°F) and used within 4 weeks or stored for up to 3 weeks at room temperature not more than 25°C (77°F). Discard any unused portions.

Commonly asked questions:

Somatropin is a medication that has been approved by the U.S. FDA mainly for the treatment of growth disorders in children and growth hormone deficiency (GHD) in adults. 

This medicinal product is supplied as injection in four dosage strengths, which are as follows:

  • Somatropin 5 mg/1.5 mL
  • Somatropin 10 mg/1.5 mL
  • Somatropin 15 mg/1.5 mL
  • Somatropin 30 mg/3 mL

Somatropin is preloaded in the Somatropin FlexPro pens for subcutaneous administration. 

Somatropin specifically is a type of medication called Immune Modulators. 

You can buy Somatropin from any authorized wholesaler after getting a prescription from a qualified doctor. It is always better to check the credential of the wholesaler/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product. 

Patients can simply fill the order form or can send mail at Patients can also send WhatsApp messages to +91 8130290915 or can dial Toll-Free number: 18008891064. We will reply ASAP with the details of the somatropin price in India as well as the procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.


All Trademarks and Brands that appear on the website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Somatropin is a pharmaceutical drug that legally requires a medical prescription to be dispensed.

The following information is meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Cooperate Sourcing, reseller and Pharmacies.